XAIRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31

Beyond Air, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$2.13−0.03 (-1.16%)

Close on Oct 19, 2026

Market cap: $1.54M
P/E (TTM): –
Dividend yield: –

Dividends

Beyond Air has not reported a dividend

No dividend per share appears in Beyond Air's annual filings since fiscal 2015.

Where these numbers come from

Parsed from the XBRL in Beyond Air's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Aug 13, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is XAIR.

Revenue growth60.7% · median 110.0%

Gross margin4.2% · median 56.9%

Operating margin-364.8% · median -107.3%

Net margin-435.7% · median -111.7%

Company	Revenue	Growth
OBIO	$31.98M	+986.1%
NSPR	$10.84M	+53.4%
MDNC	$10.21M	-10.9%
XAIR	$7.69M	+60.7%
AURX	$5.20M	+166.6%
BDMD	–	–

Company

Next earnings (est.): Nov 13, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: March 31
Employees: 54
Held by institutions: 0.0%
Auditor: WithumSmith+Brown, PC
SEC CIK: 1641631

Advertisement
300 × 250